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Abstract
Elevated plasma levels of homocysteine have been shown to interfere with normal cell function in a variety of tissues and
organs, such as the vascular wall and the liver. However, the molecular mechanisms behind homocysteine effects are not
completely understood. In order to better characterize the cellular effects of homocysteine, we have searched for changes in
gene expression induced by this amino acid. Our results show that homocysteine is able to induce the expression and
synthesis of the tissue inhibitor of metalloproteinases-1 (TIMP-1) in a variety of cell types ranging from vascular smooth
muscle cells to hepatocytes, HepG2 cells and hepatic stellate cells. In this latter cell type, homocysteine also stimulated K1(I)
procollagen mRNA expression. TIMP-1 induction by homocysteine appears to be mediated by its thiol group. Additionally,
we demonstrate that homocysteine is able to promote activating protein-1 (AP-1) binding activity, which has been shown to
be critical for TIMP-1 induction. Our findings suggest that homocysteine may alter extracellular matrix homeostasis on
diverse tissular backgrounds besides the vascular wall. The liver could be considered as another target for such action of
homocysteine. Consequently, the elevated plasma levels of this amino acid found in different pathological or nutritional
circumstances may cooperate with other agents, such as ethanol, in the onset of liver fibrosis. ß 1999 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Elevated blood levels of homocysteine, an inter-
mediate metabolite of methionine, have been identi-
¢ed as an independent risk factor for peripheral vas-
cular disease and arteriosclerosis (reviewed in [1]).
Hyperhomocysteinemia is caused by genetic factors,
such as cystathionine L-synthase de¢ciency [2], and
acquired conditions including de¢cient intake of vi-
tamin B6, B12 and folate [3], required for homocys-
teine metabolism. Additionally, impaired liver func-
0925-4439 / 99 / $ ^ see front matter ß 1999 Elsevier Science B.V. All rights reserved.
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Abbreviations: VSMC, vascular smooth muscle cell ; TIMP,
tissue inhibitor of metalloproteinases; HSC, hepatic stellate
cell ; ECM, extracellular matrix; MMP, matrix metalloprotein-
ase; PCR, polymerase chain reaction; EMSA, electrophoretic
mobility shift assay; AP-1, activating protein 1; DTT, dithio-
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tion has been associated with elevated plasma levels
of this amino acid [4^7]. This last situation probably
stems from the central role of the liver in the metab-
olism of methionine and subsequently in the catabo-
lism of homocysteine [8,9].
Regarding the pathological mechanisms behind
homocysteine-induced cellular toxicity it has been
observed that di¡erent cell types can be targeted by
this amino acid. Endothelial injury resulting in a de-
ranged NO production, and consequently an im-
paired platelet modulating activity has been clearly
established [10,11]. Along with this e¡ect on the ves-
sel wall, homocysteine is able to promote DNA syn-
thesis and to enhance collagen production in vascular
smooth muscle cells (VSMCs) [12^15]. In addition, it
has been recently demonstrated that hepatic cells
produce and secrete more cholesterol in response to
homocysteine [16]. Taken together, these observa-
tions suggest that homocysteine exerts its e¡ects on
a variety of cellular backgrounds, and thus the dele-
terious consequences of hyperhomocysteinemia may
spread over di¡erent tissues and organs.
In order to gain more insight into the molecular
mechanisms responsible for the interference of ho-
mocysteine in normal cell function, we have searched
for genes whose expression could be altered in the
presence of physiopathological concentrations of this
amino acid. In this report, we describe the induction
by homocysteine of the tissue inhibitor of metallo-
proteinases-1 (TIMP-1) [17]. This e¡ect of homocys-
teine, that we initially observed in VSMCs in culture,
could be demonstrated in other cell types, such as
hepatic stellate cells (HSC) and hepatocytes. TIMP-
1 is a low molecular weight glycoprotein that plays a
key role in the regulation of extracellular matrix
(ECM) accumulation through its ability to inhibit
matrix metalloproteinases (MMPs). When TIMP-1
is produced in excess the net MMP activity is re-
duced. This situation has been proposed to be of
importance in the development of liver ¢brosis [18].
High TIMP-1 levels have been observed in diseased
human liver [19,20] and experimental models of liver
injury [20^22], situations in which elevated plasma
concentrations of homocysteine occur [4^7]. Our re-
sults showing a direct e¡ect of homocysteine on the
induction of TIMP-1 and K1(I) procollagen expres-
sion suggest that elevated levels of this amino acid
may participate in the pathogenesis of liver ¢brosis.
2. Materials and methods
2.1. Materials
D,L-Homocysteine was from Sigma (St. Louis,
MO). Cell culture media, fetal bovine serum and
antibiotics were from Gibco-BRL (Paisley, UK).
Anti TIMP-1 monoclonal antibody was from Calbio-
chem (San Diego, CA). Radioactive isotopes were
purchased from Amersham (Little Chalfont, UK).
All other reagents were of the best quality commer-
cially available.
2.2. Methods
2.2.1. Cell culture
The hepatic stellate cells (HSC) clone CFSC-2G
derived from CCL4-treated rats [23], kindly provided
by Dr. Marcos Rojkind, was maintained in minimal
essential medium (MEM) supplemented with 10%
fetal calf serum and non-essential amino acids. This
cell line has a similar phenotype to that of freshly
isolated HSC. Human hepatoma cell line HepG2 was
kept in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) plus 10% fetal calf serum. In all the cases,
media was supplemented with 2 mmol/l glutamine,
100 U/ml penicillin and 50 mg/ml streptomycin sul-
fate. All experiments with these cells were performed
in serum-free medium supplemented with 0.2% bo-
vine serum albumin fraction V (Sigma).
Human VSMCs were isolated from mammary ar-
tery using the explant method, accordingly with pre-
viously described procedures [24]. Porcine VSMCs
were isolated from aorta of Yucatan mini-pigs, in
sterile conditions, immediately after animal sacri¢ce.
Immunohistochemical characterization of VSMC
isolates was performed on primary cultures, using
speci¢c antibodies against smooth muscle speci¢c
K-actin (Dako, High Wycombe, UK). VSMCs were
grown in DMEM supplemented with antibiotics as
described above plus fungizone (Gibco-BRL) and
10% fetal calf serum. Experiments described herein
used di¡erent isolates of VSMC between passages 3
and 6. Subcon£uent cultures of VSMCs were washed
twice with DMEM and rendered quiescent by serum
deprivation and maintenance in serum-free medium
(DMEM/F12, Gibco-BRL) containing insulin, trans-
ferrin and sodium selenite (ITS-x, Gibco-BRL) for
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48 h before the beginning of the experimental proce-
dures. Incubations with D,L-homocysteine were car-
ried out in serum-free DMEM medium.
Rat hepatocytes were isolated and cultured as pre-
viously described [25]. Cultures were kept in 0.5%
fetal calf serum for 16 h before treatments, which
were carried out in the absence of serum.
All cells were maintained at 37‡C in a humidi¢ed
incubator containing 21% oxygen and 5% carbon
dioxide in air.
The investigation was performed in accordance
with the European Community guidelines for animal
ethical care and use of laboratory animals (Directive
86/609), and ful¢lled the ethical requirements of this
University.
2.2.2. Di¡erential display analysis
Total cellular RNA was isolated by extraction
with guanidinium thiocyanate followed by centrifu-
gation in a cesium chloride solution as previously
described [26]. A 25-Wg amount of total RNA was
incubated for 30 min at 37‡C with 10 U of RNase-
free DNase I (Boehringer Mannheim, Mannheim,
Germany) in 10 mmol/l Tris HCl pH 7.5, 10 mmol/
l MgCl2, then samples were phenol:chloroform ex-
tracted and ethanol precipitated in the presence of
0.3 mol/l sodium acetate. RNA was redissolved in
sterile nuclease-free water.
Di¡erential display was performed using oligo(dT)
anchored primers [26,27] with the Hieroglyph
mRNA Pro¢le Kit (Genomyx, Beckman Instru-
ments, Fullerton, CA) following the manufacturer’s
instructions with some modi¢cations. First strand
cDNA synthesis was performed with 2 Wl of
DNase-treated total RNA (0.1 Wg/Wl) and 2 Wl of
oligo(dT) anchored primer (2 Wmol/l) using First-
Strand cDNA Synthesis Kit (Pharmacia Biotech,
Barcelona, Spain) in a Perkin-Elmer GeneAmp
2400 thermal cycler at 25‡C (10 min), 42‡C (60 min)
and 70‡C (15 min). The polymerase chain reaction
(PCR) started by adding 2 Wl of the cDNA solution
to a mixture containing 9.95 Wl of sterile nuclease-
free water, 1.2 Wl MgCl2 (25 mmol/l), 1.6 Wl dNTP
mix (1:1:1:1) (250 Wmol/l ea) (Boehringer Mann-
heim), 2 Wl 5P-arbitrary primer (2 Wmol/l), 2 Wl
3P-oligo(dT) anchored primer (2 Wmol/l), 2 Wl Ampli-
Taq Bu¡er (10U), 0.2 Wl AmpliTaq enzyme (5 U/Wl)
(Perkin-Elmer, Branchburg, NJ), and 0.25 Wl
[K-33P]dATP (10 WCi/Wl). Thermal cycling parameters
using GeneAmp 2400 thermal cycler were as follows:
92‡C (2 min), 4 cycles at 92‡C (15 s), 46‡C (30 s), and
72‡C (2 min), 30 cycles at 92‡C (15 s), 60‡C (30 s),
and 72‡C (2 min), and an additional ¢nal extension
step at 72‡C for 7 min. Reactions were performed
with each cDNA solution in duplicate. Control reac-
tions were set using sterile nuclease-free water or
each DNase-treated RNA instead of the cDNA so-
lution.
Following di¡erential display PCR, radiolabeled
cDNA fragments were electrophoretically separated
on 4.5% polyacrylamide gels under denaturing con-
ditions in a Genomyx LR DNA sequencer (Ge-
nomyx, Beckman). Gels were dried and exposed to
produce an autoradiograph. Bands of interest were
excised from the gel, and the gels slides were placed
directly into PCR tubes and covered with 40 Wl of
PCR mix (24.4 Wl sterile nuclease-free water, 3.2 Wl
dNTP mix, 4 Wl T7 promoter 22-mer primer (2 Wmol/
l), 4 Wl M13 reverse 24-mer primer (2 Wmol/l), 2.4 Wl
MgCl2 (25 mmol/l), 4 Wl AmpliTaq PCR Bu¡er
(10U), and 0.4 Wl AmpliTaq enzyme (5 U/Wl)).
PCR was performed as follows: 95‡C (2 min),
4 cycles at 92‡C (15 s), 50‡C (30 s), and 72‡C
(2 min), 30 cycles at 92‡C (15 s), 60‡C (30 s), and
72‡C (2 min), and an additional extension step at
72‡C for 7 min. Ampli¢ed DNA fragments were
cloned into the plasmid vector pCR2:1-TOPO using
TOPO-TA Cloning Kit (Invitrogen, Leek, The Neth-
erlands) and sequenced in both directions using M13
reverse (324) primer and M1 forward (320) primer.
Nucleotide sequence homology search analysis of the
EMBL [28] and GeneBank [29] databases were per-
formed using the program FASTA [30].
2.2.3. RNA isolation and Northern blot analysis
Total RNA from the di¡erent cell lines used was
isolated by the guanidinium thiocyanate method [31].
Aliquots (20 Wg) of total RNA were size-fractionated
by electrophoresis in a 1% agarose gel under dena-
turing conditions. RNAs were then blotted and ¢xed
to Nytran membranes (Schleicher and Schuell,
Keene, NH). Prehybridization and hybridization
were performed as described previously [32]. Probes
used were the isolated clone from di¡erential display
(clone 3.3) and a 1.6-kb cDNA fragment of procol-
lagen K1 [33]. Equal loading of the gels was assessed
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by hybridization with a probe speci¢c for L-actin.
The probes were labeled with [K-32P]dCTP (3000
Ci/mmol) by random priming using the Megaprime
DNA labeling system (Amersham). Speci¢c activity
was usually approximately 5U108 cpm/Wg of DNA.
Quantitation was performed by scanning densitome-
try of the X-ray ¢lms.
2.2.4. Immunoblot analysis
Conditioned media from equal number of HepG2
cells were collected after treatments and concentrated
10-fold using Centricon 3 concentrators (Amicon,
Beverly, MA). Samples were subjected to 12.5% so-
dium dodecyl sulfate-polyacrylamide gel electropho-
resis. Proteins were electrophoretically transferred to
nitrocellulose membranes (Schleicher and Schuell).
Immunodetection of TIMP-1 was performed using
a monoclonal anti TIMP-1 antiserum (Calbiochem)
and a horseradish peroxidase-conjugated secondary
antibody. Blots were developed by enhanced chemi-
luminescence according to the manufacturer’s in-
structions (Dupont, Boston, MA).
2.2.5. Nuclear protein extraction and electrophoretic
mobility shift assays (EMSA)
Rat hepatocytes were incubated in low serum
(0.5%) for 16 h before treatment. Nuclear proteins
from control and treated cells were isolated following
the method described by Schreiber et al. [34]. An
oligonucleotide containing the AP-1 consensus se-
quence (5P-TTCCGGGTGACTCATCAAGCG-3P)
(Promega), was labeled with [Q-32P]ATP using T4
polynucleotide kinase. The reaction mixture (25 Wl
¢nal volume) containing 40% glycerol, 1 Wg of
dIdC, 10 mmol/l EDTA, 20 mmol/l DTT,
100 mmol/l Tris HCl bu¡er pH 7.5, 10 000 cpm of
labeled oligonucleotide and 10 Wg of nuclear extract
was incubated for 30 min at room temperature.
DNA^protein complexes were separated from un-
bound probe by electrophoresis on a 5% polyacryl-
amide gel. Complexes formed were identi¢ed by
autoradiography of the dried gels. For competition
studies, the reaction was carried out as described
above, but in the presence of the indicated concen-
tration of unlabeled probe.
2.2.6. Statistics
The data shown are the means þ S.E.M. of at least
three independent experiments. Statistical signi¢-
cance was estimated with Student’s t-test. A P-value
of less than 0.05 was considered signi¢cant.
3. Results
Di¡erential display analysis was carried out on
human VSMCs isolated from mammary artery. Cells
were made quiescent by serum deprivation and
then treated with 100 Wmol/l of homocysteine, a con-
centration compatible with intermediate hyperhomo-
cysteinemia [1], for 24 h in DMEM medium. After
this treatment total RNA was isolated and the di¡er-
ential display analysis was performed as described
Fig. 1. Detection of di¡erential gene expression induced by ho-
mocysteine treatment in human VSMCs by di¡erential mRNA
display analysis. (A) Sequencing gel electrophoresis of PCR am-
pli¢ed cDNAs performed in duplicates, from control (C) and
homocysteine (100 Wmol/l, 24 h) (H) treated cells. A di¡eren-
tially displayed fragment (arrow) was detected, isolated, se-
quenced and identi¢ed as a 0.6-kb fragment of TIMP-1 cDNA.
(B) Northern blot analysis of total RNA from control (C) and
homocysteine treated (H) human VSMCs performed with
TIMP-1 cDNA fragment. This assay con¢rmed its di¡erential
expression between control and treated cells, detecting a 0.9-kb
transcript which was induced upon treatment. (C) Northern
blot analysis of total RNA from control (C) and homocysteine
(100 Wmol/l for 24 h) treated (H) pig VSMCs performed with
TIMP-1 cDNA fragment. (D) Northern blot analysis of total
RNA from control (C) and homocysteine (H) (150 Wmol/l)
treated rat HSCs. Blots were sequentially probed with L-actin
as loading control. The migration of ribosomal markers is indi-
cated. Representative blots are shown.
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in Section 2. Several bands were di¡erentially ex-
pressed in cells treated with homocysteine as com-
pared with control cultures. One of the bands se-
lected for analysis, whose expression was induced
in homocysteine-treated cells (Fig. 1A), was excised
from the gel, ampli¢ed and sequenced. This clone
of about 0.6 kb (termed clone 3.3) had a sequence
100% identical to part of the human TIMP-1 cDNA
Fig. 2. Induction of TIMP-1 and K1(I) procollagen expression by homocysteine. (A) Rat HSCs were treated for 4 h with di¡erent
doses of homocysteine and TIMP-1 mRNA levels were determined by Northern blotting. (B) Dose-dependent induction of K1(I) pro-
collagen mRNA in HSCs cells treated for 4 h with increasing concentrations of homocysteine assayed by Northern blotting. (C) E¡ect
of homocysteine (500 Wmol/l) on TIMP-1 mRNA expression in cultured rat hepatocytes after di¡erent incubation times. Blots were
probed with L-actin for loading control. Representative blots are shown. (D) Detection of TIMP-1 immunoreactivity in the condi-
tioned media of human hepatoma HepG2 cells treated with di¡erent concentrations of homocysteine for 24 h. Conditioned media
were concentrated and analyzed by Western blotting, a single band of about 29 kDa was detected which was signi¢cantly increased
upon treatment with respect to the untreated control cells (C). A representative blot is shown. Asterisks denote statistical signi¢cance
(*statistically di¡erent (P6 0.05) to control value, **statistically di¡erent (P6 0.05) to control value and previous dose/time point).
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(nucleotides 165^615) [35] and could hybridize a
0.9-kb mRNA in total cellular RNA from human
VSMCs (Fig. 1B). The band detected in Northern
blot by clone 3.3 corresponded in size to that re-
ported for TIMP-1 transcript in other human cell
lines [36,37], and was induced 2-fold upon treatment
with homocysteine, thus con¢rming the induction
detected in the di¡erential display gel. The e¡ect of
homocysteine on TIMP-1 expression was also tested
on VSMCs obtained from pig aorta. As shown in
Fig. 1C, incubation of these cells with 100 Wmol/l
of homocysteine for 24 h resulted in a 2.5-fold
induction in TIMP-1 mRNA, demonstrating that
this e¡ect was not species speci¢c. Given the central
role played by HSC in liver matrix biology [38,39],
we next examined TIMP-1 levels in response to
homocysteine in a rat HSC line. As shown in Fig.
1D, treatment of HSC with 150 Wmol/l of homo-
cysteine for 4 h resulted in a 1.5-fold increase in
TIMP-1 mRNA levels. HSC response to homocys-
teine was maximal after 4 h of treatment and dose-
dependency was studied at this time point as shown
in Fig. 2A. Homocysteine has been reported to in-
duce the expression of K1(I) procollagen mRNA
and to promote collagen synthesis in VSMCs in cul-
ture [13,14]. We have examined whether homocys-
teine could elicit a similar response on HSCs. Treat-
ment of HSCs with increasing concentrations of
homocysteine resulted in a dose-dependent increase
in K1(I) procollagen mRNA, reproducing in this cell
type the response described by others in VSMCs
(Fig. 2B).
Another important source of TIMP-1 within the
liver tissue is the parenchymal cell. TIMP-1 is in-
duced in hepatocytes in diseased human liver [40]
and in di¡erent models of liver injury as well as in
rat hepatocytes in primary culture by cytokines [41].
These observations prompted us to examine whether
homocysteine could promote a similar response in
isolated rat hepatocytes. Treatment of cultured rat
hepatocytes with di¡erent concentrations of homo-
cysteine resulted in the induction of TIMP-1
mRNA. Fig. 2C shows TIMP-1 mRNA levels in re-
sponse to 500 Wmol/l homocysteine (the concentra-
tion which elicited a maximal e¡ect) after 8 and 24 h
of incubation (Fig. 2C). We next tested whether ho-
mocysteine induction of TIMP-1 mRNA resulted in
enhanced production of TIMP-1 protein. For this
purpose we used the di¡erentiated human hepatoma
cell line HepG2, a hepatic cell line in which TIMP-1
expression and secretion has been thoroughly char-
acterized in response to cytokines and phorbol esters
[42]. HepG2 cells were incubated in the presence of
increasing concentrations of homocysteine for 24 h in
serum free DMEM, then conditioned media were
collected and concentrated as described in Section
2. Samples were analyzed for the presence of
TIMP-1 protein by Western blotting. As shown in
Fig. 2D, homocysteine induced a dose-dependent ac-
cumulation of TIMP-1 protein in the medium of
treated cells, as evidenced by the detection of a single
29-kDa band, the reported size of TIMP-1 protein
[17]. This e¡ect was already observed at 50 Wmol/l
homocysteine and was maximal at 250 Wmol/l.
It has been suggested that some cellular e¡ects of
homocysteine could be mediated by its thiol group
[13,14]. We have tested the e¡ect of other thiol-con-
taining reagents, such as cysteine and L-mercapto-
ethanol, on TIMP-1 expression. Treatment of HSCs
for 4 h with these compounds (at concentrations of
500 Wmol/l) resulted in the upregulation of TIMP-1
mRNA (Fig. 3). Interestingly, methionine treatment
for the same period of time also promoted TIMP-1
Fig. 3. TIMP-1 induction in HSCs by thiol-bearing agents and
methionine. HSCs were treated with 500 Wmol/l of homocys-
teine, methionine, cysteine or L-mercaptoethanol for 4 h,
TIMP-1 mRNA levels were assayed by Northern blotting. Blots
were probed with L-acting for loading control, a representative
blot is shown. Asterisks denote statistical signi¢cance
(P6 0.05).
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expression. It must be noted, however, that regular
culture media already contain methionine and cys-
teine at concentrations of 300 Wmol/l.
In the regulation of TIMP-1 gene expression, AP-1
elements present in its promoter have been shown to
play a critical role in mediating the response to se-
rum factors and other agonists, such as phorbol es-
ters [43,44]. These observations, together with the
ability of homocysteine to induce protein kinase C
(PKC) and MAP kinase activation and c-fos expres-
sion [45,46], led us to examine if homocysteine could
induce AP-1 binding activity. For this purpose rat
hepatocytes were treated with di¡erent concentra-
tions of homocysteine, then nuclear extracts were
prepared and subjected to EMSA analysis using an
oligonucleotide containing the consensus AP-1 se-
quence. Homocysteine treatment for 2 h of cultured
rat hepatocytes resulted in the dose dependent induc-
tion of a speci¢c bandshift (Fig. 4A), which could be
competed by an excess of the same unlabeled oligo-
nucleotide harboring the consensus AP-1 binding site
and was not competed by a random oligonucleotide
of the same length (Fig. 4B).
4. Discussion
Hyperhomocysteinemia is a condition in which
plasma levels of homocysteine are transiently or per-
sistently elevated. This situation may develop as a
consequence of a variety of genetic backgrounds,
such as de¢ciencies in cystathionine L-synthase or
methylenetetrahydrofolate reductase, and pathologi-
cal or nutritional conditions leading to vitamin B6,
B12 or folate de¢ciencies [1]. In addition, impaired
liver function may lead as well to the elevation of
plasma homocysteine. In this regard, hyperhomocys-
teinemia has been reported in chronic alcohol con-
sumption with a homocysteine plasma concentration
up to 40 Wmol/l [6,7]. This homocysteine elevation
also appears in experimental models of ethanol and
CCl4-induced liver damage (2.5- and 20-fold increase
above basal levels of homocysteine respectively) [4,5],
probably re£ecting the central role played by this
organ in homocysteine catabolism [9]. While the
mechanisms that lead to an increased plasma homo-
cysteine have been quite well established, the molec-
ular basis of homocysteine-mediated alteration of
Fig. 4. E¡ect of homocysteine on DNA binding activity of AP-1 assayed by EMSA analysis. (A) Nuclear extracts from cultured rat
hepatocytes treated for 2 h with di¡erent concentrations of homocysteine were incubated with 32P-labeled AP-1 oligonucleotide en-
compassing the AP-1 consensus motif and analyzed by EMSA. The position of speci¢c complexes is indicated. (B) 5- and 50-fold mo-
lar excess of speci¢c unlabeled oligonucleotides were added to the binding reactions to show the speci¢city of the AP-1 complexes.
Fifty-fold molar excess of a random oligonucleotide of the same size did not compete with the speci¢c AP-1 complexes induced by
homocysteine.
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cellular function are not completely understood. In
an e¡ort to gain more insight into this issue we have
searched for genes whose expression could be modu-
lated by this amino acid. For this purpose we have
carried out di¡erential display analysis in VSMCs, a
well characterized cellular target of homocysteine. In
this cell type, homocysteine promotes DNA synthesis
and cell growth, and enhances collagen production
[12^15,45]. One of the homocysteine-respondent
genes identi¢ed in our study coded for the TIMP-1
protein. TIMP-1 is a member of the tissue inhibitor
of the metalloproteinases family, a secretory glyco-
protein able to control the activity of MMPs through
the direct interaction with these enzymes [17]. We
have observed that homocysteine upregulates
TIMP-1 mRNA levels in primary cultures of human
and pig VSMCs. This novel action of homocysteine
provides further information on the mechanisms by
which this amino acid promotes net collagen deposi-
tion in the atherosclerotic lesion [11,47]. Given the
central role that TIMP-1 plays in the regulation of
ECM homeostasis we wanted to know whether this
response to homocysteine would also take place in
another scenario, such as liver tissue, in which matrix
production has to be tightly controlled. Our results
indicate that homocysteine is able to promote TIMP-
1 mRNA expression in a HSCs clone and cultured
hepatocytes, as well as the secretion of TIMP-1 pro-
tein by the hepatic cell line HepG2. Nevertheless, it
would be interesting to determine whether TIMP-1
induction by homocysteine occurs in freshly isolated
HSCs as it does in our HSC cell line, which in some
aspects behave like activated HSCs. We have also
observed that homocysteine promotes the expression
of K1(I) procollagen mRNA in our HSCs clone. This
later e¡ect has been already reported for VSMCs in
culture treated with homocysteine [13,14] and togeth-
er with our present ¢ndings support a role for ho-
mocysteine in the regulation of ECM homeostasis in
diverse tissular backgrounds.
Enhanced TIMP-1 production by HSCs and hep-
atocytes has been documented in experimental mod-
els of cholestatic and CCl4-induced liver damage
[22,48] and in patients with chronic liver disease
[19,20,40]. Additionally, elevated plasma levels of
TIMP-1 have been proposed as an early marker of
¢brosis and precirrhotic states in humans [49]. As
mentioned above, most of these situations of liver
damage are accompanied by a rise in plasma homo-
cysteine. However, to our knowledge, a direct role
for this amino acid in the impairment of liver
ECM regulation had not been so far established.
Interestingly, the hepatic lesion observed in patients
with homocystinuria, characterized by fatty in¢ltra-
tion, can be accompanied by perisinusoidal or central
venous ¢brosis and ¢brosis of hepatic arterioles [50].
Previous studies have reported on the role of ho-
mocysteine thiol group in mediating many of the
cellular e¡ects of this amino acid [13^15]. We have
tested whether other thiol-bearing compounds could
have an e¡ect on TIMP-1 mRNA expression. Treat-
ment of HSCs with cysteine or L-mercaptoethanol
resulted as well in the induction of TIMP-1
mRNA. Interestingly, methionine treatment gave a
similar response. This might be explained by its rapid
metabolic conversion into homocysteine [8,51,52].
These observations are in agreement with the previ-
ously reported induction of collagen synthesis by cys-
teine in VSMCs [14] and TIMP-1 expression in ¢bro-
blasts in response to reduced glutathione [53], and
support the hypothesis of the implication of homo-
cysteine sulfhydryl group in the mediation of some of
the biological e¡ects of this amino acid. Although
the observed e¡ect of cysteine on TIMP-1 induction
may be of interest from a mechanistic point of view
regarding a thiol-mediated e¡ect, this e¡ect is un-
likely to have physiological or pathological signi¢-
cance. Such high cysteine concentrations are not ob-
served even in patients with defects in cysteine
metabolism [54], while the concentrations of homo-
cysteine used in our experiments can be found in
patients with intermediate and severe hyperhomocys-
teinemia [1].
The control of TIMP-1 expression, which mainly
occurs at the transcriptional level, has been thor-
oughly characterized. The study of its promoter re-
gion has allowed the identi¢cation of the transcrip-
tion factors critical for its regulation [43,44]. In this
regard, AP-1 has been shown as one of the key fac-
tors that interact with TIMP-1 promoter and activate
its transcription. This information, together with the
recently described ability of homocysteine to pro-
mote PKC and MAP kinase activation and c-fos in-
duction [45,46], prompted us to evaluate whether ho-
mocysteine treatment could result in an increased
AP-1 binding activity. Our results indicate that this
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is the case, as evidenced by the appearance of speci¢c
bandshifts for AP-1 in EMSA assays using nuclear
extracts from rat hepatocytes treated with homocys-
teine. Our data agree with the previously reported
induction of AP-1 by other thiol reagents, such as
dithiocarbamates and N-acetylcysteine, which are
able to promote c-fos and c-jun induction [55].
Taken together, our results indicate that homocys-
teine may contribute to the deposition of ECM by
di¡erent, but converging mechanisms. In response to
elevated levels of homocysteine cells such as VSMC
and HSC respond producing more collagen. The
concomitant induction of TIMP-1 in the same cell
types and in neighboring hepatocytes would prevent
its degradation favoring the net accumulation of
ECM. In the vascular wall, this would result in the
promotion of atherogenesis while in the liver tissue,
the same situation may favor the progression of liver
¢brosis. Furthermore, the elevated plasma levels of
homocysteine, that accompany chronic alcohol con-
sumption, genetic defects in its metabolism, and vi-
tamin de¢ciencies, could be considered as a novel
risk factor for liver disease. Homocysteine may
thus cooperate in the onset of liver ¢brosis under
diverse pathological circumstances potentiating the
e¡ects of other agents, such as ethanol and cytokines
[56].
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